dengu
viru
caus
million
infect
per
year
thu
consid
one
aggress
arthropodborn
human
pathogen
worldwid
replic
dengu
viru
induc
dramat
alter
intracellular
membran
infect
cell
phenomenon
observ
human
vectorderiv
cell
use
highresolut
mass
spectrometri
mosquito
cell
show
membran
remodel
directli
link
uniqu
lipid
repertoir
induc
dengu
viru
infect
specif
metabolit
detect
significantli
differ
denv
infect
uninfect
cell
metabolit
detect
significantli
differ
isol
replic
complex
membran
furthermor
demonstr
intracellular
lipid
redistribut
induc
inhibit
fatti
acid
synthas
ratelimit
enzym
lipid
biosynthesi
suffici
cell
surviv
inhibitori
dengu
viru
replic
lipid
capac
destabil
chang
curvatur
membran
well
lipid
chang
permeabl
membran
enrich
dengu
viru
infect
cell
sever
sphingolipid
bioactiv
signal
molecul
involv
control
membran
fusion
fission
traffick
well
molecul
influenc
cytoskelet
reorgan
also
regul
dengu
infect
observ
shed
light
emerg
role
lipid
shape
membran
protein
environ
viral
infect
suggest
membraneorgan
principl
may
influenc
virusinduc
intracellular
membran
architectur
past
year
becom
increasingli
evid
lipid
import
bioactiv
molecul
mediat
signal
cascad
regulatori
event
cell
abil
synthes
lipid
predispos
organ
function
host
parasit
lost
lack
trait
virus
oblig
parasit
reli
exclus
host
fulfil
membran
lipid
requir
especi
true
envelop
virus
sinc
util
hostderiv
lipid
membran
facilit
releas
infect
cell
bud
well
enter
cell
membran
fusion
lipid
also
form
integr
structur
compon
viru
particl
virus
replic
cytoplasm
infect
cell
lipid
essenti
replic
viral
genom
envelop
nonenvelop
virus
induc
extens
ultrastructur
chang
infect
cell
hostderiv
membran
rearrang
provid
extens
platform
help
assembl
array
replic
factori
factori
hous
special
membran
compart
assist
evad
host
antivir
defens
mechan
compart
also
function
increas
local
concentr
molecul
necessari
effici
viral
rna
replic
particl
assembl
recent
advanc
electron
tomographi
techniqu
instrument
provid
threedimension
perspect
virusinduc
membran
howev
metabol
cost
host
vector
contribut
lipid
biosynthesi
traffick
format
replic
factori
yet
earli
stage
investig
studi
focus
import
lipid
biosynthesi
dengu
viru
denv
replic
denv
one
aggress
reemerg
pathogen
worldwid
two
half
billion
peopl
endem
countri
risk
contract
dengu
fever
current
million
case
dengu
fever
estim
annual
sinc
denv
replic
within
mosquito
vector
well
human
host
spread
viru
greatli
reduc
control
vector
much
effort
place
understand
dynam
viru
transmiss
replic
mosquito
vector
includ
identif
host
protein
midgut
salivari
gland
regul
denv
infect
less
known
global
impact
denv
host
metabol
pathway
previou
electron
microscopi
studi
denv
infect
mosquito
cell
shown
virusinduc
membran
structur
similar
observ
human
cell
preval
extens
requir
host
vector
intracellular
membran
support
viral
rna
replic
assembl
suggest
quantifi
chang
may
exist
lipid
repertoir
infect
cell
assist
format
membran
identifi
lipid
chang
occur
infect
necessari
first
step
discov
denv
constitu
protein
modifi
lipid
metabol
cell
reason
modif
yet
describ
pursu
knowledg
lipid
chang
occur
furthermor
novel
therapeut
modifi
inhibit
lipid
chang
lipidprotein
interact
could
conceiv
result
inhibit
viru
replic
investig
possibl
use
highresolut
mass
spectrometri
method
profil
lipidom
denv
infect
mosquito
cell
identifi
sever
lipid
class
regul
denv
infect
mani
lipid
characterist
role
influenc
membran
architectur
well
function
cellular
signal
transduct
pathway
specif
identifi
differ
induc
lipid
profil
upon
viru
bind
entri
alon
compar
induc
viral
rna
replic
assembl
egress
also
profil
lipidom
cell
treat
inhibitor
de
novo
phospholipid
biosynthesi
identifi
lipid
environ
support
cell
surviv
yet
inhibitori
denv
replic
previous
shown
fatti
acid
biosynthesi
key
target
denv
human
cell
rate
limit
enzym
fatti
acid
synthas
fa
requir
reloc
site
viral
rna
replic
denv
infect
studi
use
inhibitor
fa
determin
requir
fatti
acid
biosynthesi
conserv
host
vector
denv
infect
presenc
denv
replic
significantli
reduc
mosquito
cell
indic
fatti
acid
biosynthesi
import
viru
viabil
figur
furthermor
time
cours
addit
figur
indic
pretreat
treatment
cell
viral
adsorpt
reduc
viru
replic
fold
signific
effect
occur
upon
addit
drug
hr
postinfect
fold
suggest
postentri
step
affect
inhibit
fa
comparison
viru
releas
supernat
intracellular
viru
indic
accumul
intracellular
viru
occur
treat
cell
data
shown
thu
block
replic
level
viru
assembl
releas
base
observ
denv
induc
signific
rearrang
membran
architectur
infect
cell
togeth
distinct
suscept
inhibitor
fa
hypothesi
lipid
biosynthesi
import
denv
replic
therefor
investig
whether
intracellular
lipid
composit
alter
denv
infect
carri
lcmsbase
analys
global
lipidom
mosquito
cell
infect
denv
differenti
chang
lipid
profil
occur
upon
exposur
infecti
viru
versu
induc
viru
entri
alon
includ
uvinactiv
denv
uvdenv
studi
inactiv
viru
capabl
bind
entri
initi
round
viral
rna
translat
abil
replic
genom
figur
show
principl
compon
analysi
pca
plot
overal
lipid
abund
mosquito
cell
infect
either
denv
uvdenv
hr
postinfect
hr
time
point
chosen
repres
peak
viral
replic
hr
time
point
repres
late
stage
replic
well
increas
cellular
stress
previou
analysi
earlier
time
point
ie
hr
postinfect
indic
concurr
increas
rna
synthesi
activ
viru
releas
substanti
chang
lipidom
infect
cell
chang
greater
higher
fold
chang
observ
hr
time
point
howev
overal
intens
express
lipid
lower
contribut
low
signal
nois
ratio
furthermor
number
speci
express
signific
level
limit
therefor
chose
pursu
later
time
point
condit
ensur
cell
infect
multipl
infect
optim
viral
rna
synthesi
occur
hr
post
infect
data
shown
total
featur
observ
lcm
analys
includ
pca
analys
plot
show
specif
segreg
lipid
profil
denv
uvdenv
expos
cell
compar
uninfect
cell
mock
tempor
regul
lipid
profil
also
observ
howev
discern
upon
analysi
individu
lipid
speci
figur
rather
pca
analysi
overal
whole
cell
analysi
dengu
viru
one
aggress
human
pathogen
worldwid
caus
million
infect
per
year
vaccin
antivir
current
effect
diseas
viru
spread
aed
aegyptii
aed
albopictu
mosquito
viral
replic
within
mosquito
vector
requir
transmiss
new
human
host
replic
cycl
viru
caus
signific
chang
membran
organ
infect
cell
virusinduc
membran
alter
help
assembl
array
viral
replic
factori
aid
viru
evad
host
antivir
defens
mechan
previous
much
effort
place
tri
identifi
viral
cellular
protein
effector
aid
viru
replic
studi
explor
role
lipid
format
extens
membran
platform
mosquito
cell
use
highresolut
mass
spectrometri
profil
lipid
composit
dengu
viru
infect
mosquito
cell
compar
uninfect
cell
identifi
sever
lipid
class
differenti
regul
dengu
viru
replic
use
inhibitor
lipid
biosynthesi
also
identifi
lipid
repertoir
inhibitori
viral
replic
knowledg
dengu
viru
util
cellular
lipid
downstream
signal
pathway
facilit
replic
provid
novel
target
could
util
develop
effect
antivir
studi
also
forerunn
futur
compar
analys
human
host
vector
membran
environ
requir
viral
replic
metabolit
identifi
significantli
anova
differ
viru
infect
cell
mock
control
base
total
number
lipid
significantli
regul
group
uninfect
infect
anova
subsequ
structur
identifi
tabl
method
overal
abund
lipid
class
follow
phosphotidylcholin
pc
phosphatidylethanolamin
pe
phosphatidylserin
ps
sphingomyelin
sm
ceramid
cer
lysophospholipid
ceramid
phosphoethanolamin
cerp
distribut
similar
membran
lipid
composit
eukaryot
cell
abund
phospholipid
pc
also
consist
membran
lipid
composit
diptera
speci
pe
predomin
pl
cerp
preferenti
express
insect
cell
also
observ
sever
lipid
differenti
regul
upon
exposur
cell
denv
uvdenv
figur
notic
howev
sever
neg
charg
lipid
class
phosphatidylglycerol
pg
phosphatidylinositol
pi
cardiolipin
absent
list
lipid
previous
report
account
lipidom
mosquito
cell
howev
whole
cell
analysi
lipid
significantli
regul
viru
infect
compar
analysi
overal
abund
lipid
speci
rel
mock
control
denv
uvdenv
expos
cell
shown
figur
b
lipid
class
significantli
regul
lipid
anova
denvinfect
cell
uniqu
express
pattern
express
lipid
molecular
speci
compar
uvdenv
infect
cell
complet
list
differenti
express
lipid
see
tabl
phospholipid
pl
whole
cell
analysi
primari
pl
significantli
regul
anova
subsequ
structur
identifi
mostli
neutral
zwitterion
ps
acid
lipid
significantli
regul
hr
postinfect
fold
upregul
pc
speci
denvinfect
cell
compar
uvdenv
mock
control
figur
later
time
point
hr
postinfect
rel
level
pc
remain
elev
denvinfect
cell
howev
differenti
express
denv
uvdenvexpos
cell
evid
figur
select
pc
speci
regul
hr
time
point
other
regul
time
point
figur
interestingli
major
pc
speci
regul
unsatur
fatti
acyl
chain
analysi
overal
fold
chang
pe
hr
time
point
figur
show
differ
virusexpos
denv
uvdenv
cell
mock
due
equal
number
individu
lipid
molecular
speci
regul
regul
figur
hr
time
point
rel
level
pe
viru
expos
cell
lower
mock
level
figur
also
limit
overlap
specif
pe
molecular
speci
regul
denvand
uvdenvexpos
cell
tabl
given
insect
cell
high
abund
pe
membran
interest
select
requir
pc
pe
denvinfect
mosquito
cell
anoth
group
pl
preferenti
express
denvinfect
cell
lysophospholipid
lpl
figur
b
lipid
result
primarili
hydrolysi
pc
phospholipas
enzym
pla
repres
pl
miss
acyl
chain
denvinfect
cell
preferenti
regul
fold
lipid
compar
uvdenv
mock
control
hr
time
point
express
slightli
regul
hr
time
point
fold
mock
uvdenv
expos
cell
lpl
undetect
hr
time
point
later
time
point
similar
slightli
mock
level
shown
figur
lpl
acyl
chain
regul
time
point
select
regul
lpl
contain
acyl
chain
earli
time
point
figur
lpl
implic
proapoptot
signal
pathway
observ
select
lpl
express
present
attract
hypothesi
chain
length
differ
may
dictat
specif
role
lpl
viru
infect
sinc
lpl
result
activ
pla
type
enzym
investig
whether
denv
infect
cell
display
higher
activ
pla
compar
uninfect
cell
util
fluoresc
pc
substrat
bodipypc
use
mass
spectrometri
monitor
hydrolysi
pc
lpc
intracellular
pla
essenti
monitor
product
bodipylpc
result
pla
mediat
metabol
pc
time
cours
denv
infect
figur
method
assay
indic
follow
hr
infect
longer
pla
activ
elev
denvinfect
cell
compar
control
highest
activ
occur
hr
postinfect
therefor
elev
level
pla
could
sourc
lpl
detect
denvinfect
cell
sphingolipid
although
origin
known
vital
compon
barrier
membran
sphingolipid
also
potent
bioactiv
molecul
regul
cell
death
growth
differenti
intracellular
traffick
primari
sphingolipid
regul
denv
infect
sphingomyelin
sm
ceramid
cer
denv
infect
cell
sm
regul
compar
control
uvdenv
mock
remain
elev
hr
hr
time
point
figur
b
furthermor
tempor
express
vari
depend
specif
molecular
speci
express
figur
tabl
uvdenv
expos
cell
show
similar
level
sm
compar
mock
hr
time
point
level
decreas
later
time
point
interestingli
analog
sm
known
ceramid
phosphoethanolamin
cerp
preferenti
express
regul
fold
uvdenv
expos
cell
hr
time
point
compar
denv
mock
figur
howev
express
level
drop
mock
later
time
point
comparison
denv
infect
cell
show
low
express
lipid
earli
time
point
fold
compar
mock
express
undetect
later
time
point
figur
b
lipid
express
abundantli
insect
cell
rather
mammalian
cell
anoth
bioactiv
sphingolipid
cer
result
either
degrad
sm
sphingomyelinas
de
novo
synthesi
condens
palmit
serin
lipid
preferenti
regul
denvinfect
cell
hr
time
point
compar
mock
sinc
sm
also
regul
similarli
denv
infect
cell
rise
cer
possibl
result
de
novo
synthesi
rather
sm
degrad
uvdenvexpos
cell
show
undetect
cer
level
hr
hr
express
fold
mock
control
sinc
concurr
decreas
sm
uvdenv
expos
cell
hr
increas
level
cer
case
could
due
degrad
sm
result
increas
cellular
stress
result
incub
cell
hr
similar
lipid
speci
cer
also
show
tempor
regul
depend
molecular
speci
express
figur
overal
comparison
pl
regul
hr
time
point
indic
lipid
class
significantli
regul
anova
denv
infect
select
molecular
speci
regul
hr
time
point
other
regul
time
point
repres
exampl
lipid
class
shown
figur
h
observ
may
repres
lipidom
differ
cell
sustain
earli
activ
denv
replic
hr
compar
experienc
advanc
cellular
stress
hr
also
interest
note
regul
observ
uvdenv
expos
cell
either
time
point
rang
fold
compar
mock
control
denv
infect
cell
show
much
higher
level
express
addit
evalu
lipid
composit
whole
cell
also
explor
possibl
profil
lipid
repertoir
specif
membran
induc
denv
given
extens
interconnect
membran
induc
denv
infect
cell
isol
morpholog
distinct
membran
prove
challeng
therefor
carri
subcellular
fraction
cell
isol
postnuclear
supernat
fraction
provid
total
membran
fraction
pellet
enrich
viral
replic
compon
remain
cytoplasm
extract
ce
confirm
pellet
inde
membran
fraction
enrich
replic
complex
compon
use
quantit
rtpcr
measur
ratio
fold
chang
repres
denvinfect
cell
uvdenv
expos
cell
compar
mock
control
lack
cone
indic
express
level
specif
lipid
signific
panel
ch
repres
lipid
molecular
speci
specif
lipid
class
significantli
regul
two
differ
time
point
data
plot
integr
lcm
peak
abund
log
scale
standard
deviat
pc
phosphatidylcholin
pe
phosphatidylethanolamin
sm
sphingomyelin
cer
ceramid
cerp
ceramid
phosphoethanolamin
lyso
lysophospholipid
see
supplementari
tabl
complet
list
lipid
featur
detect
studi
four
replic
includ
lipidom
analys
error
bar
repres
standard
deviat
mean
blue
dash
line
separ
speci
remain
elev
time
point
hr
speci
elev
hr
time
point
infect
carri
use
moi
cell
significantli
express
lipid
speci
shown
denot
asterisk
viral
rna
lipid
ce
fraction
lipid
quantifi
pulsechas
analysi
use
cacet
label
newli
synthes
lipid
result
shown
figur
postnuclear
supernat
increas
incorpor
cacet
lipid
denv
infect
cell
compar
mock
control
figur
increas
observ
hr
hr
postinfect
latter
time
point
show
greater
differ
denv
mock
detail
analysi
lipid
distribut
subcellular
fraction
ce
shown
figur
hr
time
point
ce
fraction
enrich
newli
synthes
lipid
compar
fraction
denv
mock
sampl
denv
show
almost
increas
compar
mock
distribut
chang
hr
time
point
pellet
enrich
newli
synthes
lipid
howev
fold
chang
denv
compar
mock
signific
identifi
primari
fraction
contain
viral
induc
membran
includ
viral
replic
complex
carri
comparison
viral
rna
genom
copi
label
lipid
ce
subcellular
fraction
figur
result
indic
membran
fraction
enrich
increas
viral
rna
compar
ce
hr
time
point
hr
time
point
ce
fraction
slightli
viral
rna
per
label
lipid
compar
fraction
base
cacet
label
studi
ce
fraction
show
increas
amount
newli
synthes
lipid
compar
fraction
hr
time
point
lipid
biosynthesi
pathway
acet
precursor
phospholipid
well
sterol
biosynthesi
therefor
label
lipid
ce
repres
phospholipid
membran
also
cholesterol
triglycerid
form
lipid
droplet
studi
lipidom
analys
carri
ce
subcellular
fraction
isol
hr
time
point
denv
infect
cell
uvdenv
expos
cell
mock
control
primari
lipid
observ
ce
fraction
sphingolipid
cholesterol
triglycerid
success
separ
use
mass
spectrometri
analys
phospholipid
observ
statist
signific
viru
infect
cell
mock
control
data
shown
therefor
focus
primari
lipidom
analysi
lipid
extract
pellet
hr
time
point
similar
whole
cell
analysi
denv
infect
cell
display
uniqu
express
profil
compar
uvdenv
mock
infect
cell
figur
metabolit
detect
significantli
regul
virusinfect
cell
compar
control
analysi
membran
fraction
also
highlight
sever
lipid
speci
detect
whole
cell
analysi
overal
fold
chang
compar
mock
significantli
express
lipid
class
membran
fraction
shown
figur
complet
list
differenti
express
lipid
see
tabl
phospholipid
regul
phospholipid
sphingolipid
sever
bioactiv
intermedi
denv
infect
cell
compar
uvdenv
mock
control
figur
amongst
specif
phospholipid
express
pe
select
regul
membran
fraction
isol
denv
infect
cell
figur
howev
primari
pe
molecular
speci
regul
lysophospholipid
pe
denv
uvdenv
expos
cell
show
similar
express
fatti
acid
figur
howev
individu
molecular
speci
express
differ
two
virus
figur
instanc
stearic
acid
regul
denv
infect
cell
oleic
acid
regul
uvdenv
expos
cell
palmit
acid
similar
level
express
denv
uvdenv
expos
cell
sever
bioactiv
intermedi
monoacylglycerol
mg
diacylglycerol
dg
phosphatid
acid
pa
also
promin
regul
denv
infect
cell
compar
control
figur
sphingolipid
although
blygh
dyer
method
util
lipidom
analys
whole
cell
membran
fraction
detect
express
sphingolipid
merril
et
al
optim
protocol
dedic
analyz
sphingolipid
without
interfer
copurifi
pl
util
protocol
carri
mass
spectrometri
analysi
bioactiv
lipid
mosquito
cell
fraction
provid
three
subcellular
fraction
nuclear
n
cytoplasm
ce
membran
similar
analys
uvdenv
mock
infect
cell
includ
control
specif
sphingolipid
monitor
includ
cer
sm
monohexosylceramid
glccer
dihexosylceramid
galcer
shown
figur
cer
level
cell
show
clear
elev
denvinfect
cell
compar
mockinfect
uvdenv
expos
cell
comparison
differ
subcellular
fraction
indic
elev
cer
primarili
concentr
ce
fraction
except
two
speci
enrich
pellet
two
speci
consist
abund
fatti
acid
observ
cell
analysi
sm
level
mosquito
cell
figur
indic
viru
expos
cell
higher
level
sm
compar
mockinfect
cell
evid
pellet
except
abund
speci
show
highest
level
ce
comparison
infecti
denv
uvdenv
expos
cell
indic
latter
incap
replic
maintain
higher
level
sm
overal
glccer
primarili
detect
pellet
denv
infect
uvdenv
expos
cell
figur
howev
overal
level
downregul
compar
mock
control
except
show
slight
elev
uvdenv
expos
cell
dihexosylceramid
detect
signific
level
sampl
fa
inhibitor
potent
inhibitor
denv
replic
mosquito
figur
mammalian
cell
cell
treat
noncytotox
concentr
mm
induc
environ
redistribut
lipid
repertoir
support
cell
surviv
absenc
fa
activ
yet
environ
support
viral
replic
determin
basi
exclus
viru
replic
profil
lipidom
cell
treat
mm
membran
fraction
isol
denv
infect
mock
control
cell
presenc
absenc
profil
hierarch
cluster
analysi
lipidom
data
figur
indic
lipid
environ
denv
infect
cell
treat
cluster
close
mock
treat
control
furthest
denv
infect
cell
suggest
two
repres
significantli
differ
environ
compar
analysi
lipid
speci
express
two
environ
indic
major
lipid
regul
denv
infect
cell
regul
upon
treatment
cell
amongst
phospholipid
sever
phosphatidylinositol
speci
regul
fold
untreat
denv
infect
cell
compar
treat
cell
figur
howev
none
pi
speci
phosphoryl
singl
speci
pg
also
regul
fold
untreat
cell
sinc
disrupt
format
lipid
stream
fa
sever
fatti
acid
stearic
palmit
acid
regul
drug
treat
cell
enrich
fatti
acid
observ
untreat
cell
upon
comparison
treat
cell
figur
contrast
observ
previou
comparison
denv
infect
cell
uninfect
cell
figur
oleic
acid
downregul
untreat
denv
infect
cell
therefor
show
enrich
treat
cell
interestingli
treat
cell
also
show
regul
metabol
intermedi
monoand
diacylglycerol
well
phosphatid
acid
enrich
lipid
observ
untreat
denv
infect
cell
compar
treat
cell
figur
addit
phospholipid
de
novo
synthesi
sphingolipid
also
disrupt
key
intermedi
pathway
npalmitoylesphingosin
nstearoylesphingosin
regul
upon
treatment
cell
regul
untreat
denv
infect
cell
figur
tabl
architectur
biolog
membran
defin
composit
distribut
lipid
protein
bilay
optim
composit
distribut
facilit
format
virusinduc
intracellular
membran
structur
requir
effici
denv
replic
previous
show
fa
ratelimit
enzym
lipid
biosynthesi
recruit
activ
denv
replic
human
cell
studi
demonstr
requir
fa
activ
also
conserv
mosquito
vectorderiv
cell
furthermor
inhibit
fa
activ
seem
effect
hr
postinfect
suggest
earli
requir
fa
activ
replic
cycl
next
step
investig
role
lipid
denv
induc
membran
expans
use
highresolut
mass
spectrometri
profil
lipid
composit
denv
infect
mosquito
cell
observ
distinct
segreg
lipid
composit
denv
infect
uninfect
cell
specif
lipid
chang
occur
upon
viru
bind
entri
alon
also
identifi
denv
infect
cell
select
enrich
lipid
characterist
function
influenc
membran
structur
well
potent
signal
function
among
lipid
bioactiv
sphingolipid
sphingomyelin
ceramid
lysophospholipid
sever
intermedi
monoand
diacylglycerol
phosphatid
acid
phospholipid
enrich
denv
infect
cell
primarili
unsatur
also
evid
regul
de
novo
phospholipid
sphingolipid
biosynthesi
well
triacylglycerid
metabol
figur
furthermor
identifi
uniqu
lipid
environ
support
cell
surviv
support
denv
replic
environ
creat
addit
inhibitor
fatti
acid
synthas
ratelimit
step
phospholipid
biosynthesi
analysi
whole
cell
lipidom
indic
unsatur
pc
regul
phospholipid
denv
infect
cell
membran
similar
deriv
er
enrich
unsatur
lipid
primarili
pc
although
denvinduc
membran
mammalian
system
erderiv
unknown
true
mosquito
cell
pc
known
form
planar
membran
unsatur
pc
induc
membran
curvatur
may
import
maintain
highli
curv
membran
observ
denvinfect
cell
pc
enrich
membran
also
fluidic
compar
rigid
membran
enrich
sm
cholesterol
may
featur
attract
denv
infect
bioactiv
sphingolipid
sm
cer
also
key
lipid
regul
denv
infect
cell
expos
replic
compet
viru
cer
regul
whole
cell
lipidom
well
replic
complex
membran
either
cellular
respons
viru
infect
direct
need
cer
viru
replic
cycl
latter
hypothesi
particularli
attract
consid
enrich
specif
molecular
speci
cer
pellet
cer
coneshap
figur
bioactiv
sphingolipid
speci
differenti
regul
replic
complex
membran
isol
denvinfect
mosquito
cell
multipl
reaction
monitor
mrm
analysi
sphingolipid
speci
differenti
regul
denvinfect
cell
moi
uvdenv
expos
cell
compar
mock
control
see
also
supplementari
tabl
data
repres
fold
chang
observ
three
subcellular
fraction
analyz
studi
replic
complex
membran
ce
cytoplasm
extract
follow
remov
replic
complex
membran
nuclei
n
nuclear
fraction
panel
ac
repres
ceramid
sphingomyelin
monohexosylceramid
speci
respect
dash
line
highlight
valu
equal
mock
data
repres
three
independ
experi
error
bar
repres
standard
deviat
mean
molecul
promot
inward
bud
membran
neg
curvatur
denvinduc
membran
show
doubl
membran
morpholog
indic
neg
curvatur
modifi
lipid
cer
may
activ
format
second
messeng
cer
also
induc
apoptosi
autophagi
howev
mosquito
cell
denv
maintain
persist
infect
antagon
apoptot
pathway
therefor
cer
regul
may
due
preval
apoptot
respons
may
util
regul
autophagi
denv
infect
shown
mammalian
cell
autophagi
regul
necessari
denv
replic
preval
sever
intermedi
cer
biogenesi
includ
npalmitoylsphingosin
diacylglycerol
suggest
observ
cer
could
result
either
de
inhibit
process
disrupt
cellular
lipid
repertoir
mosquito
cell
unfavor
viru
replic
lipidom
analys
reveal
regul
fatti
acid
palmit
stearic
acid
fatti
acid
intermedi
biosynthesi
phospholipid
regul
denv
infect
interestingli
denv
infect
cell
preval
phospholipid
primarili
consist
unsatur
acyl
chain
long
chain
fatti
acid
significantli
regul
infect
fa
activ
also
stimul
de
novo
sphingolipid
biosynthesi
lipidom
analys
regul
intermedi
npalmitoylesphingosin
suggest
sphingolipid
biosynthesi
activ
denv
infect
specif
sm
cer
enrich
denv
infect
cell
altern
regul
cer
dg
infect
could
result
degrad
sm
activ
sphingomyelinas
smase
result
cer
dg
could
redirect
sever
signal
pathway
util
de
novo
phospholipid
biosynthesi
glycopshingolipid
glccer
galcer
regul
denv
infect
suggest
catabol
produc
cer
lipidom
analys
also
suggest
regul
triacylglycerol
catabol
lipolysi
denv
infect
cell
pathway
result
gener
mg
dg
palmit
acid
intermedi
regul
denv
infect
cell
could
util
downstream
signal
de
novo
phospholipid
biosynthesi
also
shown
tg
catabol
necessari
mitochondri
boxid
denv
infect
elev
level
lpc
denv
infect
cell
also
suggest
activ
pc
hydrolysi
pla
enzym
activ
denv
infect
elev
level
phospholipid
pa
pi
pe
pg
well
pc
suggest
cdgdg
pathway
phospholipid
biosynthesi
could
also
activ
fa
fatti
acid
synthas
denv
dengu
viru
inhibitor
fa
sm
sphingomyelin
cer
ceramid
mg
monoacylglycerol
dg
diacylglycerol
tg
triacylglycerol
lpc
lysophosphatidylcholin
pla
phospholipas
pa
phosphatid
acid
pi
phosphatidylinositol
pe
phosphatidylethanolamin
pg
phosphatidylglycerol
pc
phosphatidylcholin
novo
synthesi
serin
palmitoyltransferas
sptlc
er
catabol
sm
sphingomyelinas
smase
plasma
membran
lipidom
analys
also
indic
regul
glccer
may
suggest
salvag
pathway
metabol
glccer
cer
may
also
activ
invert
coneshap
lipid
lpl
also
regul
denv
infect
primarili
lpc
regul
whole
cell
analysi
result
hydrolysi
pc
pla
shown
enzym
activ
denv
infect
mani
virus
also
shown
depend
pla
life
cycl
due
invert
coneshap
structur
asymmetr
incorpor
lpc
membran
caus
posit
curvatur
induc
vesicl
fission
bud
structur
analys
denvinduc
membran
structur
mosquito
cell
indic
presenc
highli
curv
membran
smaller
vesicl
therefor
vesicul
fission
bud
well
enrich
molecul
increas
membran
curvatur
may
underli
mechan
form
membran
structur
lpc
also
increas
permeabl
membran
attract
concept
given
denv
replic
complex
encas
within
membran
barrier
need
facilit
exchang
compon
cytosol
genom
replic
viru
assembl
therefor
leaki
membran
may
favor
denvinfect
cell
select
incorpor
molecul
lpc
anoth
observ
give
credenc
hypothesi
transmembran
permeabil
effect
lpc
synergist
enhanc
presenc
palmit
acid
also
regul
denvinfect
cell
signal
molecul
lpc
prosurviv
well
inflammatori
molecul
therefor
express
denv
infect
cell
could
cellular
respons
viral
infect
previous
report
de
novo
lipid
biosynthesi
regul
denv
infect
consist
observ
sever
primari
fatti
acid
palmit
stearic
oleic
acid
involv
biosynthesi
higher
order
pl
detect
lipidom
analys
palmit
acid
first
fatti
acid
lipogenesi
pathway
stearic
acid
immedi
downstream
palmit
acid
regul
denv
infect
cell
latter
precursor
biosynthesi
oleic
acid
long
chain
fatti
acid
acyl
chain
greater
interestingli
sinc
oleic
acid
regul
denvinfect
cell
stearic
acid
may
stimul
long
chain
fa
biosynthesi
howev
major
pl
express
denv
infect
cell
chain
vari
degre
unsatur
therefor
seem
desatur
palmit
stearic
acid
rather
elong
may
chosen
pathway
lipogenesi
denv
infect
sever
intermedi
lipid
catabol
also
detect
replic
complex
membran
palmit
acid
mg
dg
analysi
intermedi
suggest
regul
pathway
pc
hydrolysi
triacylglycerol
tg
metabol
latter
pathway
respons
regul
lipid
homeostasi
energi
product
cell
metabol
lipid
droplet
action
lipas
degrad
lipid
droplet
result
releas
palmit
acid
dg
mg
metabol
product
substrat
mitochondri
boxid
well
intermedi
fatti
acid
synthesi
new
lipid
denv
infect
cell
show
high
preval
speci
compar
mock
infect
cell
sever
acid
phospholipid
speci
detect
membran
fraction
significantli
regul
infect
previou
studi
mammalian
cell
indic
import
acid
lipid
denv
infect
neg
charg
lipid
also
implic
influenc
membran
structur
strike
result
obtain
comparison
denv
infect
cell
presenc
absenc
fa
inhibitor
well
establish
treatment
cell
inhibitor
disrupt
de
novo
phospholipid
biosynthesi
circumv
inhibit
cell
redistribut
lipid
repertoir
ensur
cell
surviv
howev
redistribut
support
denv
replic
comparison
differ
lipid
environ
indic
mani
lipid
regul
denv
infect
cell
compar
cell
treat
similar
previous
observ
infect
cell
compar
mock
uninfect
control
therefor
comparison
denv
infect
cell
two
differ
control
uninfect
cell
treat
infect
cell
highlight
lipid
regul
activ
denv
infect
studi
util
uvdenv
control
identifi
lipid
metabol
chang
occur
upon
viru
bind
entri
alon
viru
incap
replic
immunofluoresc
microscopi
antibodi
indic
low
level
translat
occur
within
first
hr
data
shown
analysi
lipidom
uvdenv
expos
cell
show
signific
differ
phospholipid
sphingolipid
content
comparison
denv
infect
cell
mock
control
possibl
bind
membran
fusion
entri
alon
express
viral
protein
incom
viral
rna
trigger
activ
lipas
lipid
transport
mechan
result
differ
observ
lipidom
cell
shown
virus
jan
et
al
shown
bind
entri
alon
sindbi
viru
trigger
activ
sphingomyelinas
degrad
membran
bound
sm
cer
also
shown
virus
induc
apoptoticsign
cascad
upon
bind
entri
alon
cascad
may
either
result
induc
lipolysi
lipid
transfer
compart
cell
pronounc
chang
observ
pellet
analys
signific
decreas
phospholipid
sphingolipid
lipid
intermedi
observ
compar
mock
cell
figur
comparison
sm
cer
whole
cell
analysi
hr
hr
time
point
figur
indic
reduct
sm
correspond
increas
cer
time
could
due
similar
scenario
sinv
nonrepl
uvdenv
capabl
induc
lipid
convers
membran
therefor
sm
sphingolipid
may
convert
cer
transport
away
membran
fraction
locat
cell
also
evid
increas
content
fatti
acid
compar
mock
cell
may
result
degrad
lipid
uvdenv
expos
cell
show
signific
regul
mg
dg
show
regul
palmit
acid
viru
bind
entri
alon
could
stimul
lipid
droplet
hydrolysi
catabol
tg
result
releas
palmit
acid
studi
shown
uvdenv
could
versatil
tool
pursu
mechanist
studi
metabol
pertab
occur
upon
viru
bind
membran
fusion
entri
summari
use
highresolut
mass
spectrometri
determin
denv
drastic
alter
lipid
profil
infect
cell
specif
denv
infect
elev
express
lipid
capac
chang
physic
properti
bilay
bilay
curvatur
permeabl
recruit
assembl
protein
complex
membran
sever
identifi
molecul
also
function
bioactiv
messeng
control
signal
membran
traffick
pathway
cell
repres
molecul
result
activ
cellular
stress
pathway
respond
viral
infect
base
find
next
step
investig
mechan
lipid
speci
play
role
denv
replic
well
identifi
control
point
pathway
may
influenc
viral
gene
product
cell
cultur
viru
infect
aed
albopictu
cell
atcc
maintain
minim
essenti
medium
mem
supplement
glutamin
mm
nonessenti
amino
acid
mm
hepe
heat
inactiv
fetal
calf
serum
dengu
viru
strain
obtain
richard
kinney
cdc
ft
collin
stock
amplifi
cell
mem
supplement
heat
inactiv
fetal
calf
serum
uvinactiv
denv
obtain
expos
viru
stock
use
infect
uvlight
hr
conform
inactiv
two
blind
passag
viru
cell
hr
per
passag
lack
infect
confirm
plaqu
assay
immunofluoresc
assay
sampl
prepar
infect
cell
infect
denv
moi
infect
cell
requir
lipidom
analys
confirm
immunofluoresc
analys
experi
includ
three
biolog
replic
follow
infect
cell
harvest
hr
postinfect
pellet
resuspend
ml
mm
ammonium
bicarbon
lipid
extract
equal
number
cell
use
modifi
bligh
dyer
protocol
briefli
mixtur
chloroform
methanol
acet
acid
butyl
hydroxi
toluen
bht
ad
cell
suspens
ammonium
bicarbon
ratio
organ
solvent
cell
follow
lipid
extract
organ
phase
separ
aqueou
phase
centrifug
dri
n
stream
low
retent
microfug
tube
fisher
dri
lipid
resuspend
ml
methanol
vortex
sampl
centrifug
g
min
remov
particul
chromatographymass
spectrometri
lipid
molecular
speci
profil
use
dualcolumn
nanocapillari
lc
system
equip
cm
column
pack
mm
jupit
particl
phenomenex
torranc
ca
mobil
phase
mm
ammonium
acet
watermethanol
vv
b
mm
ammonium
acet
methanolacetonitril
vv
lc
system
equilibr
psi
mobil
phase
prior
inject
ml
sampl
exponenti
gradient
elut
initi
min
sampl
load
initi
column
flow
nlmin
min
gradient
separ
mobil
phase
mixer
purg
ml
mobil
phase
b
follow
min
column
wash
final
mobil
phase
mixer
purg
ml
mobil
phase
repres
end
one
separ
cycl
gradient
elut
perform
one
column
column
equilibr
mobil
phase
lc
system
coupl
hybrid
linear
iontraporbitrap
mass
spectromet
thermofish
san
jose
ca
capillari
temperatur
electrospray
voltag
kv
respect
orbitrap
use
mass
analyz
ms
survey
scan
mz
rang
duti
cycl
datadepend
msm
perform
ltq
top
ion
normal
collis
energi
dynam
exclus
ltq
datadepend
msm
experi
enabl
follow
repeat
count
repeat
durat
exclus
list
size
exclus
durat
data
process
lcm
dataset
defin
data
obtain
singl
lcm
analysi
process
use
prism
data
analysi
system
seri
softwar
tool
freeli
avail
http
ncrrpnlgovsoftwar
develop
inhous
first
step
involv
deisotop
raw
ms
data
give
monoisotop
mass
charg
state
intens
major
peak
mass
spectrum
use
data
next
examin
fashion
use
multialign
identifi
group
mass
spectral
peak
observ
sequenti
spectra
use
algorithm
comput
euclidean
distanc
ndimension
space
combin
peak
group
gener
ascrib
one
detect
speci
refer
featur
median
monoisotop
mass
central
normal
elut
time
net
abund
estim
comput
sum
intens
ms
peak
compris
entir
lcm
featur
lcm
featur
chromatograph
align
across
dataset
use
lcmswarp
algorithm
multialign
lipid
ident
detect
featur
initi
determin
compar
measur
monoisotop
mass
net
calcul
monoisotop
mass
observ
net
lipid
amt
tag
databas
within
search
toler
ppm
net
monoisotop
mass
elut
time
respect
subsequ
identif
lipid
featur
match
entri
amt
tag
databas
made
search
molecular
weight
entri
lipid
map
databas
follow
manual
confirm
base
ms
ms
spectra
statist
analysi
process
data
follow
chromatograph
align
databas
match
abund
detect
featur
amt
tag
databas
match
unmatch
load
dant
statist
analysi
featur
abund
transform
scale
subject
central
tendenc
normal
compar
data
analysi
perform
statist
signific
differ
lipid
profil
sampl
determin
use
anova
partial
leastsquar
pl
analysi
also
perform
use
data
matric
contain
either
amt
tag
databas
match
featur
alon
featur
databas
match
unmatch
homogen
centrifug
g
min
remov
nuclei
postnuclear
supernat
centrifug
min
obtain
membran
pellet
refer
pellet
supernat
post
nuclear
membran
fraction
refer
cytoplasm
extract
ce
total
rna
extract
fraction
ce
use
trizol
reagent
sigma
accord
manufactur
instruct
follow
rna
extract
total
lipid
extract
use
bligh
dyer
method
mention
count
use
beckman
ls
scintil
counter
viral
rna
fraction
measur
use
superscript
iii
platinum
sybr
green
onestep
qpcr
kit
rox
denv
specif
primer
forward
acaagtcgaacaacctggtccat
revers
gccgcaccattggtcttctc
appli
biosystem
real
time
pcr
machin
label
lipid
subcellular
fraction
standard
total
rna
isol
fraction
prior
determin
viral
rna
genom
copi
per
label
lipid
subcellular
fraction
sampl
prepar
profil
lipidom
replic
complex
membran
lipid
extract
pellet
use
modifi
blygh
dyer
protocol
describ
liquid
chromatographymass
spectrometri
profil
analysi
lipid
content
ltq
orbitrap
xl
instrument
thermo
fisher
scientif
san
jose
ca
use
analysi
coupl
agil
seri
lc
agil
technolog
santa
clara
ca
equip
micro
well
plate
auto
sampler
binari
pump
devic
revers
phase
liquid
chromatographi
use
analyz
sampl
agil
eclips
column
mm
mm
dimens
use
separ
solvent
consist
water
piperidin
solvent
b
contain
acetonitril
methanol
vv
piperidin
flow
rate
mlminut
volum
ml
load
onto
column
gradient
follow
time
minut
b
time
minut
b
time
minut
b
time
minut
b
time
minut
b
ms
analysi
use
neg
polar
electrospray
ioniz
sourc
voltag
kv
sourc
current
capillari
voltag
v
tube
len
voltag
v
capillari
temperatur
sheath
ga
flow
auxiliari
sweep
ga
set
data
acquir
use
data
depend
scan
mode
ftm
resolut
mass
rang
use
full
scan
analysi
itm
use
msm
data
acquisit
top
three
intens
ion
acquir
minimum
signal
isol
width
normal
collis
energi
default
charg
state
activ
q
activ
time
sampl
evalu
thermo
xcalibur
softwar
version
downstream
align
done
inhous
data
process
packag
call
omic
discoveri
pipelin
liquid
chromatographymass
spectrometri
target
sphingolipid
analysi
method
slightli
modifi
briefli
sampl
extract
accord
publish
protocol
dri
reconstitut
ml
methanol
water
formic
acid
contain
mm
ammonium
format
agil
qqq
agil
technolog
santa
clara
ca
use
analysi
coupl
seri
lc
equip
hplc
chip
interfac
agil
technolog
santa
clara
ca
solvent
consist
methanol
water
formic
acid
follow
sourc
condit
ga
temperatur
ga
flow
lminut
capillari
voltag
v
fragmentor
voltag
set
v
case
data
process
agil
mass
hunter
softwar
version
cell
infect
denv
moi
follow
adsorpt
viru
remov
cell
wash
overlay
media
contain
vari
concentr
vehicl
ethanol
viru
supernat
harvest
hr
postinfect
viru
titer
assay
plaqu
assay
cytotox
simultan
assay
use
quick
cell
prolifer
kit
abcam
time
addit
cell
infect
denv
describ
indic
time
point
mm
ad
cell
cell
harvest
hr
postinfect
amount
releas
viru
determin
plaqu
assay
lipidom
studi
cell
infect
denv
describ
left
uninfect
follow
adsorpt
viru
room
temperatur
hr
ad
media
overlay
cell
incub
hr
sampl
prepar
lipid
extract
mass
spectrometri
analys
carri
describ
fraction
pellet
sampl
phospholipas
activ
monitor
use
redgreen
bodipi
substrat
invitrogen
use
similar
method
describ
cell
infect
denv
moi
plate
follow
viru
adsorpt
cell
overlay
mem
supplement
heat
inactiv
fetal
calf
serum
mlwell
indic
time
point
media
remov
new
media
mlwell
contain
mm
fluorogen
phospholipas
substrat
bodipypc
ad
cell
cell
incub
min
follow
incub
media
remov
cell
wash
lipid
extract
use
mlwell
aqueou
fraction
discard
lipid
butanol
phase
analyz
mass
spectrometri
monitor
convers
bodipypc
bodipi
lcp
pla
phospholipas
activ
analysi
lipid
sampl
reconstitut
ml
methanol
water
formic
acid
contain
mm
ammonium
format
analyz
agil
qqq
agil
technolog
santa
clara
ca
coupl
seri
lc
equip
hplc
chip
interfac
agil
technolog
santa
clara
ca
solvent
consist
methanol
water
formic
acid
contain
mm
ammonium
format
solvent
b
methanol
formic
acid
contain
mm
ammonium
format
gradient
follow
time
minut
b
time
minut
b
time
minut
b
time
minut
b
time
minut
b
time
minut
b
flow
rate
mlmin
data
acquir
parent
ion
correspond
bodipypc
mz
bodipi
lcp
mz
singl
ion
monitor
sim
mode
follow
sourc
condit
ga
temperatur
ga
flow
lminut
capillari
voltag
v
fragment
voltag
set
v
case
data
process
agil
mass
hunter
softwar
version
supplement
data
includ
three
figur
three
tabl
carri
lipid
condit
time
point
follow
inform
provid
treatment
p
pvalu
anova
analysi
minimum
observ
data
exact
mass
mass
lipid
http
wwwlipidmapsorg
mh
proton
molecular
ion
net
normal
elut
time
total
carbondoubl
bond
correspond
lipid
speci
detect
lmid
identif
lipid
display
lipid
map
formula
element
composit
lipid
ppm
error
differ
experiment
mass
compar
exact
mass
fold
denvmock
fold
chang
averag
abund
replic
treatment
ident
abbrevi
made
phoshatidylcholin
pc
ofatti
acid
chain
number
mean
alkyl
acyl
linkag
glycerol
chain
present
respect
pc
phosphatidylethnolamin
pe
phosphatidylserin
ps
sphingomyelin
sm
ceramid
cer
ceramid
phosphoethanolamin
cerp
lysophosphatidylcholin
lpc
notat
indic
total
number
carbon
doubl
bond
howev
discern
redund
associ
vari
fatti
acid
composit
molecular
weight
access
number
lmid
obtain
lipid
map
gateway
lipidmapsorg
pdf
tabl
select
list
lipid
speci
analysi
membran
fraction
isol
mosquito
cell
treat
condit
describ
regul
across
condit
condit
mock
uninfect
cell
denv
infecti
dengu
viru
type
strain
uvdenv
uvinactiv
dengu
viru
type
strain
total
featur
detect
mass
spectrometri
analysi
follow
normal
mock
denv
uvdenv
treat
sampl
featur
significantli
regul
identif
success
lipid
ppm
error
condit
follow
inform
provid
pttest
pwilcox
pvalu
minimum
observ
data
measur
must
present
two
three
replic
consid
present
exact
mass
mass
lipid
http
wwwlipidmapsorg
mz
mass
charg
ratio
rt
retent
time
formula
element
composit
lipid
ppm
error
differ
experiment
mass
compar
exact
mass
fold
denvmock
fold
uvdenvmock
fold
chang
averag
abund
replic
treatment
ident
abbrevi
made
phoshatidylcholin
pc
phosphatidylethnolamin
pe
phosphatidylglycerol
pg
ofatti
acid
chain
number
mean
alkyl
acyl
linkag
glycerol
chain
present
respect
pg
sphingomyelin
sm
monoacylglycerol
mg
diacylglycerol
dg
phosphatid
acid
pa
access
number
obtain
lipid
map
gateway
lipidmapsorg
human
metabolom
databas
hmdbca
pdf
tabl
select
list
lipid
speci
analysi
membran
fraction
isol
mosquito
cell
treat
condit
describ
regul
across
condit
condit
denv
cell
infect
denv
presenc
vehicl
denv
cell
infect
denv
treat
fa
inhibitor
total
featur
detect
mass
spectrometri
analysi
follow
normal
denv
denv
treat
sampl
featur
significantli
regul
identif
success
lipid
ppm
error
condit
follow
inform
provid
pttest
pwilcox
pvalu
minimum
observ
data
measur
must
present
two
three
replic
consid
present
exact
mass
mass
lipid
http
wwwlipidmapsorg
mz
mass
charg
ratio
rt
retent
time
formula
element
composit
lipid
ppm
error
differ
experiment
mass
compar
exact
mass
fold
denvdenv
fold
chang
averag
abund
replic
treatment
ident
abbrevi
made
phoshatidylinositol
pi
phosphatidyllglycerol
pg
monoacylglycerol
mg
diacylglycerol
dg
phosphatid
acid
pa
access
number
obtain
lipid
map
gateway
lipidmapsorg
human
metabolom
databas
hmdbca
pdf
